WANY
TDOC icon

Wealthspire Advisors (New York)’s Teladoc Health TDOC Stock Holding History

Wealthspire Advisors (New York)’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,046
Closed -$8.09K – 2695
2025
Q3 		$8.09K Buy
+1,046
New +$8.16K ﹤0.01% 2124
2021
Q2 		– Sell
-1,185
Closed -$215K – 628
2021
Q1 		$215K Buy
+1,185
New +$275K 0.01% 656
2020
Q2 		– Sell
-3,176
Closed -$492K – 501
2020
Q1 		$492K Buy
+3,176
New +$369K 0.02% 295

Other funds holding TDOC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JAM
Jupiter Asset Management London, United Kingdom $18.8B AUM 29.2% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Wealthspire Advisors (New York)'s TDOC Position: Q4 2025 in Review

Wealthspire Advisors (New York) sold out of Teladoc Health (TDOC) in Q4 2025, closing a stake of 1,046 shares — an estimated $8.09K sold.

Wealthspire Advisors (New York) first reported a position in TDOC in Q1 2020 and held it in 3 quarters. The position peaked at $492K in Q1 2020. 345 funds tracked by Wall St. Rank hold TDOC as of Q4 2025.

  • Wealthspire Advisors (New York) reported no remaining Teladoc Health position as of Q4 2025 after selling out during the quarter.
  • Wealthspire Advisors (New York) sold 1,046 Teladoc Health shares in Q4 2025, an estimated $8.09K.
  • Wealthspire Advisors (New York) first reported a position in Teladoc Health in Q1 2020 and held it in 3 quarters.
  • Wealthspire Advisors (New York)'s Teladoc Health position peaked at $492K in Q1 2020.
  • 345 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2025.

Based on Wealthspire Advisors (New York)'s 13F filing for Q4 2025, filed 13 Feb 2026.